Texas Top Legal Officer Files Lawsuit Against Acetaminophen Makers Concerning Autism Claims

Courtroom Proceedings
Ken Paxton, a Trump ally seeking election to US Senate, claimed the drug companies of concealing safety concerns of acetaminophen

Texas Attorney General Ken Paxton is suing the producers of acetaminophen, asserting the companies hid safety concerns that the medication posed to children's neurological development.

This legal action arrives thirty days after President Donald Trump promoted an unsubstantiated connection between taking acetaminophen - also known as acetaminophen - while pregnant and autism spectrum disorder in offspring.

The attorney general is suing J&J, which formerly manufactured the medication, the sole analgesic suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "misled consumers by making money from pain and marketing drugs ignoring the risks."

Kenvue says there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, deliberately risking numerous people to increase profits," the attorney general, a Republican, declared.

Kenvue commented that it was "seriously troubled by the perpetuation of misinformation on the safety of acetaminophen and the possible consequences that could have on the welfare of women and children in America."

On its website, Kenvue also said it had "consistently assessed the relevant science and there is insufficient valid information that indicates a proven link between using paracetamol and autism spectrum disorder."

Associations speaking for physicians and health professionals agree.

ACOG has declared acetaminophen - the main ingredient in acetaminophen - is one of the few options for pregnant women to treat pain and fever, which can present serious health risks if not addressed.

"In more than two decades of investigation on the use of acetaminophen in pregnancy, no reliable research has successfully concluded that the use of acetaminophen in any trimester of pregnancy results in neurodevelopmental disorders in children," the organization said.

The lawsuit cites current declarations from the former administration in arguing the drug is reportedly hazardous.

Last month, the former president raised alarms from health experts when he advised pregnant women to "fight like hell" not to take Tylenol when unwell.

The US Food and Drug Administration then issued a notice that physicians should consider limiting the usage of Tylenol, while also stating that "a direct connection" between the drug and autism in young ones has not been established.

The Health Department head Kennedy, who manages the Food and Drug Administration, had vowed in April to undertake "extensive scientific investigation" that would establish the origin of autism spectrum disorder in a matter of months.

But experts cautioned that finding a unique factor of autism - considered by experts to be the outcome of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that influences how people perceive and interact with the environment, and is diagnosed using doctors' observations.

In his legal document, Paxton - aligned with the former president who is campaigning for the Senate - asserts Kenvue and J&J "willfully ignored and sought to suppress the science" around paracetamol and autism spectrum disorder.

This legal action aims to force the companies "destroy any promotional materials" that claims Tylenol is safe for pregnant women.

The Texas lawsuit echoes the grievances of a assembly of guardians of children with autism and attention deficit hyperactivity disorder who sued the producers of Tylenol in recently.

Judicial authorities rejected the legal action, stating research from the family's specialists was not conclusive.

Sonya Williams
Sonya Williams

Elara is a passionate writer and digital storyteller with over a decade of experience in blogging and creative nonfiction.